Trending...
- Launch of Def Leppard beauty collection creating Hysteria in the makeup industry
- Our Hungry Kitchen: Enjoy Making And Preparing Your Favorite Dishes For Friends And Family
- Speede Fitness draws massive crowds at IHRSA as company continues to disrupt the fitness industry
CHICAGO--(BUSINESS WIRE)--SonarMD, the leading care coordination company for gut health, will present an abstract at Digestive Disease Week (DDW) 2022 demonstrating the importance of proactive screening for mental health conditions in patients with inflammatory bowel diseases (IBD). SonarMD is using this data to identify and connect IBD patients to services that promote emotional well-being and healthy sleep, via new partnerships with Happy and Rise Science.
SonarMD will present abstract at DDW
Mental health issues like emotional distress and poor sleep can worsen IBD outcomes and increase the risk of hospitalization and surgery, driving up the cost of care. But patients with these co-morbidities cannot be fully identified by retrospective claims data alone, according to new data being presented at DDW.
SonarMD data reveals a nearly 40% increase in cost of care for IBD patients who have a positive depression screening score but no mental health claim in their history, compared to the general IBD population. That's nearly twice the cost increase than when analyzing retrospective claims data alone.
More on illi News
"Mental health can have a major impact on the course of disease for patients with chronic digestive illness, but challenges often go undetected," said Lawrence Kosinski, MD, MBA, lead abstract author and SonarMD's founder and chief medical officer. "We have to be proactive in screening patients and connecting them to clinically relevant services that meet their individual needs — before those needs become health emergencies."
In addition to the data being presented at DDW, SonarMD has previously shown care costs are 26% higher for IBD patients with claims related to sleep disorders.
The SonarMD platform uniquely combines multi-payer claims data, clinical information and patient-reported outcome measures, including Patient Health Questionnaire 2 (PHQ-2) depression screening scores, to better identify patients who would benefit from additional support services.
SonarMD expands to support whole person care
To help patients better manage their health, SonarMD is piloting partnerships with Happy and Rise Science to deliver emotional health and sleep management support at no cost to patients or practices. RISE is an app that uses sleep and circadian science and phone data to help patients improve their sleep and manage their energy, and Happy is a peer-based service pioneering "frictionless mental health" that uses a proactive engagement model to improve patients' emotional wellbeing and reduce barriers to care. SonarMD is introducing these holistic services with the first patient cohorts this spring. This launch will also establish wearable device integrations for seamless remote monitoring, supporting future incremental expansions in diet and nutrition and beyond.
"I'm excited to see SonarMD offer more holistic tools and services in the care management of our patients with inflammatory bowel disease," said Nadeem Baig, MD, vice president of Allied Digestive Health and chief medical officer of the Allied Health Management Services Organization. "SonarMD is an extension of our practice, so these new services further augment our ability to manage the health and well-being of our patients with chronic disease."
More on illi News
DDW poster details
Session Title: Health Economics (Cost of Illness, Cost-Effectiveness, and Health Economic Models)
Session Sponsor: AGA
Session Date and Time: May 23, 2022 from 12:30 PM to 1:30 PM
Poster Presentation Title: MENTAL HEALTH DISORDERS ARE ASSOCIATED WITH INCREASED COST IN IBD PATIENTS – USE OF RETROSPECTIVE CLAIMS DATA AND PHQ-2 CAN IDENTIFY HIGH-RISK HIGH-COST POPULATIONS OF IBD
Poster Number: Mo1057
About Digestive Disease Week® (DDW)
Digestive Disease Week® (DDW) is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Jointly sponsored by the American Association for the Study of Liver Diseases (AASLD), the American Gastroenterological Association (AGA) Institute, the American Society for Gastrointestinal Endoscopy (ASGE) and the Society for Surgery of the Alimentary Tract (SSAT), DDW takes place May 21 – 24 in San Diego, California and virtually. The meeting showcases more than 3,100 abstracts and hundreds of lectures on the latest advances in GI research, medicine and technology. More information can be found at www.ddw.org.
About SonarMD
SonarMD aligns incentives around the doctor-patient relationship to reimagine care for complex chronic diseases, starting in gastroenterology. Using AI technology and human support, we predict clinical deterioration in patients and make it easier for patients and specialists to work together to proactively address problems before they become health emergencies. Our approach is proven to keep people healthier and help health plans reduce costs by 15% per member per year. For more information, visit SonarMD.com.
Contacts
Patty Keiler, patty@collaborate.health, 312-550-5394
SonarMD will present abstract at DDW
Mental health issues like emotional distress and poor sleep can worsen IBD outcomes and increase the risk of hospitalization and surgery, driving up the cost of care. But patients with these co-morbidities cannot be fully identified by retrospective claims data alone, according to new data being presented at DDW.
SonarMD data reveals a nearly 40% increase in cost of care for IBD patients who have a positive depression screening score but no mental health claim in their history, compared to the general IBD population. That's nearly twice the cost increase than when analyzing retrospective claims data alone.
More on illi News
- Signs By Veterans and Savage Shakers Founder Announces Sponsorship for #TEAMUSA Para-Athlete Brian Conwell
- InventHelp Inventor Develops Safe & Simple Way to See Behind You (CLR-107)
- Michael Jordan's Rare Bulls Playoff Jersey Could Fetch Up To $1,000,000 At Auction and Will Help Feed Homeless Families in The Chicago Area USA - English USA - English
- Polynt Group Announces North American Coatings Capacity Expansion
- XAI Octagon Floating Rate & Alternative Income Term Trust Closes Private Placement of Convertible Preferred Shares and Registered Direct Placement of Common Shares
"Mental health can have a major impact on the course of disease for patients with chronic digestive illness, but challenges often go undetected," said Lawrence Kosinski, MD, MBA, lead abstract author and SonarMD's founder and chief medical officer. "We have to be proactive in screening patients and connecting them to clinically relevant services that meet their individual needs — before those needs become health emergencies."
In addition to the data being presented at DDW, SonarMD has previously shown care costs are 26% higher for IBD patients with claims related to sleep disorders.
The SonarMD platform uniquely combines multi-payer claims data, clinical information and patient-reported outcome measures, including Patient Health Questionnaire 2 (PHQ-2) depression screening scores, to better identify patients who would benefit from additional support services.
SonarMD expands to support whole person care
To help patients better manage their health, SonarMD is piloting partnerships with Happy and Rise Science to deliver emotional health and sleep management support at no cost to patients or practices. RISE is an app that uses sleep and circadian science and phone data to help patients improve their sleep and manage their energy, and Happy is a peer-based service pioneering "frictionless mental health" that uses a proactive engagement model to improve patients' emotional wellbeing and reduce barriers to care. SonarMD is introducing these holistic services with the first patient cohorts this spring. This launch will also establish wearable device integrations for seamless remote monitoring, supporting future incremental expansions in diet and nutrition and beyond.
"I'm excited to see SonarMD offer more holistic tools and services in the care management of our patients with inflammatory bowel disease," said Nadeem Baig, MD, vice president of Allied Digestive Health and chief medical officer of the Allied Health Management Services Organization. "SonarMD is an extension of our practice, so these new services further augment our ability to manage the health and well-being of our patients with chronic disease."
More on illi News
- Indie Brand Vow Beauty Enters Walmart
- Discover Financial Services Announces Second Quarter 2022 Earnings Release on July 20,2022, and Conference Call on July 21, 2022
- Chicago: Statement from Mayor Lori E. Lightfoot
- James Postrasija, CEO of Order Food Online on Platform Features/Benefits
- Disney Good Neighbor Hotel Lulu is Open for the Summer
DDW poster details
Session Title: Health Economics (Cost of Illness, Cost-Effectiveness, and Health Economic Models)
Session Sponsor: AGA
Session Date and Time: May 23, 2022 from 12:30 PM to 1:30 PM
Poster Presentation Title: MENTAL HEALTH DISORDERS ARE ASSOCIATED WITH INCREASED COST IN IBD PATIENTS – USE OF RETROSPECTIVE CLAIMS DATA AND PHQ-2 CAN IDENTIFY HIGH-RISK HIGH-COST POPULATIONS OF IBD
Poster Number: Mo1057
About Digestive Disease Week® (DDW)
Digestive Disease Week® (DDW) is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Jointly sponsored by the American Association for the Study of Liver Diseases (AASLD), the American Gastroenterological Association (AGA) Institute, the American Society for Gastrointestinal Endoscopy (ASGE) and the Society for Surgery of the Alimentary Tract (SSAT), DDW takes place May 21 – 24 in San Diego, California and virtually. The meeting showcases more than 3,100 abstracts and hundreds of lectures on the latest advances in GI research, medicine and technology. More information can be found at www.ddw.org.
About SonarMD
SonarMD aligns incentives around the doctor-patient relationship to reimagine care for complex chronic diseases, starting in gastroenterology. Using AI technology and human support, we predict clinical deterioration in patients and make it easier for patients and specialists to work together to proactively address problems before they become health emergencies. Our approach is proven to keep people healthier and help health plans reduce costs by 15% per member per year. For more information, visit SonarMD.com.
Contacts
Patty Keiler, patty@collaborate.health, 312-550-5394
Filed Under: Business
0 Comments
Latest on illi News
- NIRI Chicago Elects 2022-2023 Officers and Directors
- AI Tech Company Nala Robotics Signs Expansion Deal with Slice Factory Pizza Chain
- Zebra Technologies Introduces New PartnerConnect Public Sector Specialization Program for Channel Partners
- New Factbook Delivers First Reference Compilation for 2022 Russia-Ukraine War
- XAI Octagon Floating Rate & Alternative Income Term Trust Announces Private Placement of Convertible Preferred Shares and Registered Direct Placement of Common Shares
- International Couture Fashion Designer Nathalie Loma Opens Her Second Store
- New ComEd Substation Brings Science to Life at Argonne National Laboratory
- Mutual Aid Ambulance Service Partners with Excela Health for Paramedic Training Program
- In2Scuba Diving Co. of Maui introduces its exclusive beginner scuba diving lessons
- Speede Fitness draws massive crowds at IHRSA as company continues to disrupt the fitness industry
- Chicago: Mayor Lightfoot Announces Michelle Mills Clement as New Board Member of the Metropolitan Pier and Exposition Authority (MPEA)
- Mill Point Capital Completes Sale of KKSP Precision Machining
- Always Ontime: Chaos City - Super Hero Graphic Novel with Neal Adams Cover Launches from Panopolis Metaverse
- Our Hungry Kitchen: Enjoy Making And Preparing Your Favorite Dishes For Friends And Family
- New Hampshire Becomes the 15th State to Require Personal Finance as a Core Academic Subject
- Virtual Workplace Platform Developer REACH Expands Executive Team, Positioning the Company to Drive International Growth
- Endevica Reports the U.S. FDA Accepted Its Investigational New Drug (IND) Application for TCMCB07, a Melanocortin‐4 Antagonist Peptide
- Health Advisory: Protecting Yourself and Others from Monkeypox
- Kindle FREE June 28-29: Powerful new memoir from Santa Molina-Marshall poised to help heal abuse victims through inspiring storytelling
- GoodLoan.io announces new program to unlock up to $500,000 for Home Equity Investment